True, indeed. So I'm not sure why a battery-based solution is the way forward.The problem with existing batteries is that they suck.
Whoever invents a better way to store electricity is going become awfully rich.
True, indeed. So I'm not sure why a battery-based solution is the way forward.The problem with existing batteries is that they suck.
I fully believe reviewers should not be given names in the review process. This way it avoids gender bias. And it avoids people thinking anything a big name says is gospel and not fully reviewing (another problem).That's the thing about the review process. It's largely anonymous and they just say whatever the hell they want. I've had some papers reviewed where one reviewer completely rips the paper apart and another praised it for the good work. Luckily there is an appeal process in pretty much any journal that consists of just writing a letter to the editor of the journal, saying the review was very unfair, and typically (if it's warranted like this example) the editor will send it out to a different reviewer. If the paper contained data and interviews from males in the field as a way to compare make and female experiences, that should be enough, they shouldn't need a male coauthor.
“Sticks and stones may break my bones, but words will never hurt me,” goes the playground rhyme that’s supposed to help children endure taunts from classmates. But a new study suggests that there’s more going on inside our brains when someone snubs us – and that the brain may have its own way of easing social pain.
The findings, recently published in Molecular Psychiatry by a University of Michigan Medical School team, show that the brain’s natural painkiller system responds to social rejection – not just physical injury.
What’s more, people who score high on a personality trait called resilience – the ability to adjust to environmental change – had the highest amount of natural painkiller activation.
Ha. I don't give a crap about the Proton, but problems with the Soyuz are disturbing when that's still the only way to get astronauts to the ISS.The Russians have poor quality control. You don't say.
And presumably back home.Ha. I don't give a crap about the Proton, but problems with the Soyuz are disturbing when that's still the only way to get astronauts to the ISS.The Russians have poor quality control. You don't say.
That as well, although the Soyuz spacecraft hasn't had any problems recently. There is some ambiguity in the term "Soyuz," since it is used to refer both to the Soyuz spacecraft and to the carrier rocket used to launch that spacecraft. The Soyuz spacecraft always launches on a Soyuz rocket, but the Soyuz rocket is used for other missions such as launching LEO satellites and launching the unmanned Progress cargo vehicles (which are based on the Soyuz spacecraft). The current Soyuz carrier rocket is nothing more than an evolved version of the original Soviet R-7 Semyorka ICBM, which was also the rocket that launched Sputnik and Yuri Gagarin's Vostok 1 mission. The R-7 turned out to be a mediocre ICBM but a good expendable launch system.And presumably back home.Ha. I don't give a crap about the Proton, but problems with the Soyuz are disturbing when that's still the only way to get astronauts to the ISS.The Russians have poor quality control. You don't say.
http://www.quora.com/Why-is-it-that-whe ... -shoots-upSteam you can see is not really steam, but in reality very hot water vapor with very small droplets of liquid water. When water is boiling a steady state of water turning into steam turning into visible "steam" is established. When heat is removed the system is no longer in a steady state and shifts quickly to a new steady state, that of water turning into less hot steam, which cools more quickly to form more visible "steam". Thus in the process of shifting to a new steady state a lot of steam will condense more rapidly to form steam clouds than before.
If the therapy can be made to work on humans, it will be amazing. This disease is actually my biggest fear about growing old; it scares the absolute crap outta me thinking that my brain may deteriorate to the point of no longer recognizing Mrs Tif, or knowing my own name.Australian researchers have come up with a non-invasive ultrasound technology that clears the brain of neurotoxic amyloid plaques - structures that are responsible for memory loss and a decline in cognitive function in Alzheimer’s patients.
That opens the question: whom would they try this out on?New Alzheimer’s treatment fully restores memory functionIf the therapy can be made to work on humans, it will be amazing. This disease is actually my biggest fear about growing old; it scares the absolute crap outta me thinking that my brain may deteriorate to the point of no longer recognizing Mrs Tif, or knowing my own name.Australian researchers have come up with a non-invasive ultrasound technology that clears the brain of neurotoxic amyloid plaques - structures that are responsible for memory loss and a decline in cognitive function in Alzheimer’s patients.
As c2i said, its all about selling your research to get more grant money to complete the research. But research like this could be a decade away from impacting anyone. Especially when its in the health field, where you have so many steps before something can be done for patients.between this thread and the one at the old board, i feel like there have been a ton of links to groundbreaking research on awful diseases...and then nothing.
it's a combination of false alarm and "these things take time", but color me skeptical when i hear stuff like this.
A novel adaptation to inductively coupled plasma–mass spectroscopy (ICP-MS), mass cytometry provides researchers with a tool to study the complexity of biology at the single-cell level. New insights into the interrogation of high dimensional data systems using unsupervised data networking algorithms are enabling the application of mass cytometry to the study of the diversity of cell subsets, as well as to determine cellular functions such as apoptosis, cell signaling pathways, the cell cycle, and DNA damage.
Mass cytometry uses reporter molecules (typically antibodies) tagged with transition-metal isotopes to label cells from blood, tissues, or cell cultures. The metal-tagged antibodies specifically bind to their target proteins, and the mass cytometer measures the expression of these biomarkers in each individual cell according to the type and amount of each metal detected. The current instrument configuration provides users with more than 120 detection channels at an acquisition rate of up to 1000 cells per second.
Users browsing this forum: Dickie Dunn and 337 guests